|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01246 BOILLHEALTHCARE
Nominal 
0.021 0.000 (0.000%) | 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | |
| Turnover | 285,204 | -18.109% | 348,271 | 1,016,162 | 216,710 | 106,352 |
| Cost of Sales | (273,549) | -21.430% | (348,161) | (907,740) | (197,739) | (95,563) |
| Gross Profit | 11,655 | 10495.455% | 110 | 108,422 | 18,971 | 10,789 |
| 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | (59,235) | -61.174% | (152,566) | (631,164) | 566 | (65,654) | |
| Change in FV & Impairment on Others | (36) | -- | 319 | (1,850) | (1,074) | (2,960) | |
| Profit / (Loss) on Disposal | 17,755 | -- | -- | -- | -- | -- | |
| Other Non-operating Items | (180,599) | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (17,721) | (940) | (3,599) | |
| Profit / (Loss) before Taxation | (275,502) | 22.644% | (224,636) | (744,781) | (180,629) | (202,919) | |
| Taxation | (7,625) | 281.632% | (1,998) | (10,954) | 5,139 | (20,875) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | (300,941) | -- | -- | -- | |
| Non-controlling Interests | 164,487 | 65.613% | 99,320 | 237,937 | 33,004 | 34,362 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (118,640) | -72.297% | (428,255) | (517,798) | (142,486) | (189,432) | |
| 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | |
| Net Finance Costs / (Income) | 21,730 | -49.959% | 43,424 | 121,631 | 119,909 | 77,606 |
| Depreciation & Amortisation | 796 | -16.122% | 949 | 22,352 | 19,738 | 9,949 |
| Directors' Emoluments | -- | -- | 2,183 | 1,100 | 1,100 | 1,200 |
| 2024/03 - Final | %Chg (Compare to Final) | 2023/03 | 2022/03 | 2021/03 | 2020/03 | |
| Auditor's Opinion Status | Disclaimer | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) |
Market Valuation Indicators
| 2024/03 - Final | %Chg (Compare to Final) | 2023/03 | 2022/03 | 2021/03 | 2020/03 | |
| EPS (cts) | -8.740 | -72.289% | -31.540 | -38.130 | -12.700 | -20.880 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.050 | (0.084) | (0.137) | 0.080 |
| NBV per share ($) | (0.245) | -- | (0.100) | (0.008) | 0.343 | 0.449 |
| Remarks: | Real time quote last updated: 14/11/2024 15:21 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -118,640,000 |
| %Change | -72.297% |
| EPS / (LPS) | HKD -0.087 |
| NBV Per Share ($) | HKD -0.245 |